AU661362B2 - Method for making a prolineboronate ester - Google Patents

Description

r OPI DATE 15/06/93 AOJP DATE 19/08/93 APPLN. ID 31368/93 PCT NUMBER PCT/US92/09845 AU9331368 iLu 1 rC.1rNAI UNAL APtLICA ION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (51) International Patent Classification 5 C07F 5/02 (11) International Publication Number: Al (43) International Publication Date: WO 93/10127 27 May 1993 (27.05.93) (21) International Application Number: (22) International Filing Date: 19 t Priority data: 07/796,148 22 Nover 07/936,198 26 Augus PCT/US92/09845 November 1992 (19.11.92) nber 1991 (22.11.91) US .t 1992 (26.08.92) US (74) Agents: FRANKHOUSER, David, E. et al.; Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, CT 06877 (US).

(81) Designated States: AU, CA. CS, FI, HU, JP, KR, NO, PL, RU, UA, European patent (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL. SE).

Published With international search report.

Af (71)Applicant: BOEHRINGER INGELHEIM PHARMA- CEUTICALS, INC. [US/US]; 900 Ridgebury Road, P.O. Box 368, Ridgefield, CT 06877 (US).

(72) Inventors: SNOW, Roger 29 East Gate, Danbury, CT 06810 KELLY, Terence, A. 81 Pinewood Circle, Danbury, CT 06810 ADAMS, Julian 270 Peaceable Street, Ridgefield, CT 06877 COUTTS, Simon 32 Fairview Road, Brookfield, CT 06804 PERRY, Clark 32 Pound Crest Road, Danbury, CT 06811 (US).

(54)Title: METHOD FOR MAKING A PROLINEBORONATE ESTER (57) Abstract A method for the preparation of esters of prolineboronic acid is described. An N-protected pyrrole is lithiated at the 2-position. The lithiated species (II) is reacted with trialkylborate, to yield a protected pyrrole-2-boronic acid (III). This is reduced to form a protected prolineboronic acid which, in turn, is reacted with a diol to yield an ester With the boronic acid moiety protected by the ester group, the protecting group on the nitrogen is removed, yielding the desired prolineboronic acid ester (VII). In an alternative synthesis, a protected pyrrolidine (VIII) is lithiated at the 2-position to yield a protected 2-lithiopyrrolidine This is reacted with trialkylborate to yield the intermediate IV. The prolineboronic acid esters so produced have a chiral center to the boron atom. Also disclosed are methods for resolving enantiomers. The final products can be coupled to activated carboxylic acids, to yield peptides having a prolineboronic acid ester, instead of an amino acid, at the C-terminus. These boronic acid peptide analogs are useful for inhibiting biologically important proteases. Several methods for removing pinanediol from pinanediol boronate esters are also disclosed.

WO 93/10127 PCT/US92/09845 1 METHOD FOR MAKING A PROLINEBORONATE ESTER Field of the Invention The invention relates to a method for making optically active prolineboronate esters. These are useful as intermediates in the production of peptides which incorporate prolineboronic acid instead of proline.

These peptides, in turn, are useful for inhibiting various biologically important proteases.

Background of the Invention Interest in boronic acid analogs of a-amino acids, as well as peptides incorporating a boronic acid analog of an a-amino acid instead of the C-terminal residue, has been generated by reports that these compounds are efficient inhibitors of many serine proteases. See, for example, Matteson et al. Am.

Chem. Soc. 103, 5241 (1981)]; Kettner et al. [J.

Biol. Chem. 259, 15106 (1984)]; and, Kinder et al.

Med. Chem. 27, 1919 (1985)].

Several workers, including Koehler et al.

[Biochemistry, 10, 2477 (1971)] and Rawn et al.

[Biochemistry, 13, 3124 (1974)] have hypothesized that the empty p-orbital centered at boron in these compounds interacts with an active-site hydroxyl group of the enzyme, to form a tetrahedral adduct that mimics the transition state of enzymatic hydrolysis.

It is thought that the boronic acid analog binds more tightly to the enzyme than does the substrate itself, thereby inhibiting enzymatic action upon the substrate.

WO 93/10127 PCT/US92/09845 2 The boronic acid analogs of a-amino acids and peptides incorporating them are currently of use in research because they are able to shed light on the biological functions of the enzymes they inhibit.

Further, as explained below, they are also therapeutically useful.

Peptides which incorporate the a-aminoboronic acid analog of proline (BoroPro) at the C-terminus are of special interest because they have been shown to be potent inhibitors of certain post-proline cleaving enzymes. For example, Bachovchin et al. Biol.

Chem. 265, 3738 (1990)] have reported that such peptides are inhibitors of IgA proteinases from certain bacteria. These enzymes are strongly implicated in bacterial virulence. Flentke et al.

[Proc. Natl. Acad. Sci. USA 88, 1556 (1991)] have reported that such peptides inhibit dipeptidyl peptidase IV (DP-IV), which in turn causes inhibition of antigen-induced proliferation and IL-2 production in T-cells. The latter effects are known to result in suppression of the immune response. Suppression of the immune response is, in turn, useful in the treatment of, for example, organ transplant rejection, graft versus host disease, and various autoimmune diseases.

Previous synthetic routes to a-amino boronic acids rely on the procedure published in 1981 by Matteson et al., supra, which follows the sequence of hydroboration, (asymmetric) homologation with chloromethyllithium, and aminolysis. Matteson et al.

[Organometallics 3, 1284 (1984)] have described the use of this technique to synthesize the boronic acid ~1 WO 93/10127 PCT/US92/09845 3 analogues of N-acetylalanine, N-acetylvaline, N-acetylleucine, and N-acetylphenylalanine; some of these have been obtained with good (9:1) diastereomeric ratios.

The application of the Matteson procedure to the synthesis of BoroPro has been demonstrated by Bachovachin, supra, and Flentke, supra, but the extensive modifications required for the construction of the pyrrolidine ring render it unappealing.

Furthermore, conditions for the preparation of a single enantiomer of BoroPro, either by asymmetric synthesis or by resolution, have not been reported.

Efforts to explore further the biochemistry of the post-proline cleaving enzymes, particularly DP-IV, and the possible therapeutic uses of BoroPro-based enzyme inhibitors, have been hampered by the lack of an efficient route to prolineboronic acid.

The need for a better source of BoroPro led us to explore alternate routes to this compound, especially the compound in its optically active form, and has resulted in the present invention.

Summary of the Invention A first broad aspect of the present invention comprises three closely related methods for the synthesis of prolineboronic acid esters. Two of these syntheses commence from pyrrole. The third commences from pyrrolidine. Included within the scope of this first aspect of the invention are certain novel intermediates. Prolineboronic acid has a chiral

I

WO 93/10127 PCT/US92/09845 4 center a to the boron atom. A second broad aspect of the invention comprises a method for resolving the enantiomers of prolineboronic acid, if desired.

I According to this method, the prolineboronic ester is formed through reaction with a chiral alcohol, with the use of pnanediol being particularly preferred.

Resolution of enantiomers is facilitated by separating the diastereomeric mixture resulting from the introduction of additional chiral centers. The resulting prolineboronic acid esters can be easily coupled to activated carboxylic acid groups, such as are typically used in peptide synthesis, to yield peptides having a prolineboronic acid ester, instead of an amino acid, at the C-terminus. The ester protecting group can be removed to yield the free boronic acid peptide. When the ester protecting group is pinanediol, it is not easily removed by known per se techniques. A third aspect of the invention comprises several methods for removing the pinanediol protecting group.

Brief Description of the Drawing Figure 1 illustrates a reaction scheme which is a preferred embodiment of the invention.

AmL Detailed Description of the Invention A first synthesis according to the invention commences with pyrrole, which is reacted with an activated derivative of carbonic acid, in order to protect the nitrogen atom with a group of the formula -COOR, wherein R is C_ 6 alkyl, C 3 _cycloalkyl, benzyl, phenyl, phenyl substituted with one or more C6 1-6 alkyl groups, or trimethylsilylethyl, in order to yield a compound of the formula I.

;i I- -I SWO 93/10127 P(7/US92/09845

N

Ro RO In the preferred protecting groups, R is tert-butyl, benzyl, trimethylsilylethyl, phenyl, methyl or ethyl.

The most preferred protecting group is tert-butyloxycarbonyl, or Boc. The protecting group is applied using well known techniques. A specific synthesis for 1-Boc-pyrrole has been described by Grehn et al. [Anqew. Chem. Int. Ed. Engl. 23, 296 (1984)].

The compound of formula I is next treated with a lithiating agent to yield a compound of the formula II SLi wherein R is defined as before.

Lithiation of the compound of formula I can be accomplished by treatment with lithium tetramethylpiperidide in a known per se manner, such as that described by Hasan et al. Org. Chem. 46, 157 (1981)], or with other hindered lithium amides such as lithium diisopropyl amide or lithium dicyclohexylamide, or with n-butyl lithium in the i i F_ WO 93/10127 PCT/US92/09845 6 presence of tetramethyl ethylenediamine. This reaction is conveniently carried out in an inert solvent, preferably an ether such as THF, diethyl ether, dimethoxyethane, or methyl t-butyl ether at a temperature between -780C and -40 0 C. Alternatively, pyrrole can be brominated at the 2-position, in a known per se manner, such as that described by Chen et al., [Org. Syn., 70, 151 (1991)], and the resulting product can be protected and then lithiated, using other less expensive lithiating agents, such as n-butyl lithium, using known per se techniques.

The intermediate of formula II, which is not isolated, is next reacted with a trialkyl borate wherein each alkyl group may be straight, branched or cyclic and contains 1 to 6 carbon atoms, preferably trimethyl or triethyl borate, followed by acid-catalyzed hydrolysis, using a weak acid such as citric or acetic acid, or potassium hydrogen sulfate, in order to yield a protected pyrrole-2-boronic acid of formula III S OH RO 0O wherein R is defined as before.

The intermediate of formula III is next reduced, using catalytic hydrogenation, to form a protected prolineboronic acid of the formula IV l 2 li E WO 93/10127 PCT/US92/09945 7

OH

N B PO

(IV)

J

RO

wherein R is defined as before.

The catalytic hydrogenation of the intermediate of formula III may be carried out in an organic solvent, such as ethyl acetate or tetrahydrofuran, using a catalyst such as 5% platinum on carbon, platinum oxide, rhodium on carbon, rhodium on alumina, palladium on carbon, or Raney nickel, either at atmospheric pressure, or at about 50 psi.

An alternative synthesis of the boronic acid of formula IV uses pyrrolidine which is treated with a suitable acylating agent, to yield a protected compound of the formula VIII I

K^

U n I L WO 93/10127 PCT/US92/09845 8

N

S(VIII)

RO wherein R is defined as before.

The protecting group is chosen to allow activation of the pyrrolidine to lithiation adjacent to the nitrogen, and it should contain a bulky moiety which hinders attack on the carbonyl by the lithiating agent. It is preferred to use a carbamoyl protecting group of the formula -COOR, for example, groups wherein R is tert-butoxy or 2,4,6-tri-tertbutylphenoxy. However, certain acyl or aroyl groups can also be used, for example tert-butylcarbonyl or triphenylmethylcarbonyl. Other suitable activating groups are outlined in Beak et al., [Chem. Rev., 84, 471-523, (1984)]. The most preferred protecting group is tert-butyloxycarbonyl, or Boc. The protecting group may be applied to pyrrolidine by well known techniques.

The compound of formula VIII is next treated with a lithiating agent to yield a compound of the formula IX L _i Y, i WO 93/10127 PCT/US92/09845 9 X LI

(IX)

RO

wherein R is defined as before.

Lithiation of the compound of formula VIII can be accomplished by treatment with sec-butyl lithium and tetramethyl ethylenediamine in a known per se manner, such as that described by Beak et al. [Tet. Lett.

1197 (1989)]. This reaction is conveniently carried out in an inert organic solvent, preferably an ether such as diethyl ether, methyl tert-butyl ether or THF at a temperature between about -78°C and 0 0

C,

preferably -78 0 C to -40 0 C. Lithiation may be achieved with a reactive alkyl lithium such as sec-butyl lithium or tert-butyl lithium, preferably in the presence of a coordinating additive such as tetramethyl ethylenediamine, hexamethyl phosphoramide or N,N'-dimethylpropyleneurea (DMPU).

The intermediate of formula IX, which is not isolated, is next reacted with a trialkyl borate wherein each alkyl group may be straight, branched or cyclic and contains 1 to 6 carbon atoms, preferably trimethyl or triethyl borate, followed by hydrolysis with water and extraction into aqueous alkali such as sodium hydroxide or potassium hydroxide to aid purification.

Acidification of the alkali solution to about pH 3 and extraction yields the protected prolineboronic acid of formula IV.

c.

:1 :1 WO 93/10127 PCT/US92/09845 In order to form a boronic acid ester, the free boronic acid intermediate of formula IV, is next esterified by reaction with a diol of the formula V, HO-X-OH

(V)

wherein X is a linking group, to yield a compound of the formula VI B 0 0X (VI) RO 0 0 wherein X is the same linking group mentioned above and R is defined as before. The ester group thus formed is intended to function only as a removable protecting group. The structures, syntheses, and methods for attachment and removal of such ester protecting groups are generally known in the chemical art. Accordingly, those skilled in the chemical art will appreciate that the structure of the linking group X is not critical. The linking group X can be, by way of non-limiting examples, a saturated 2- to 3-membered hydrocarbon chain; a saturated 2- to 3-membered hydrocarbon chain which constitutes part of a C-12 carbocyclic system which may optionally contain unsaturations or ring fusions; a 2- to 3-membered hydrocarbon chain which constitutes part of an aromatic ring system; or, a group of the formula j I- h i WO 93/10127 PCT/US92/09845 11 -(CH2)n-NH-(CH2)m-, wherein n and m are each 2 or 3; wherein such groups may be unsubstituted or substituted by one or more Cl_ alkyl or phenyl groups.

Accordingly, suitable diols of formula V are, for example, ethylene glycol, pinacol, catechol, pinanediol, butan-2,3-diol, 2,2-dimethyl propan 1,3-diol, diethanolamine and 1,2-diphenylethan- 1,2-diol.

With the boronic acid moiety protected by the ester group, the protecting group on the nitrogen is next removed using known per se techniques, such as those described by Greene in "Protective Groups in Organic Synthesis" Wiley Sons, 1981), to yield the hydrochloride of the desired prolineboronic acid ester of the formula VII.

B (VII) H 0 For example, when the protecting group is Boc, it may be easily removed with dry hydrogen chloride in ethyl acetate.

It is preferred to perform the esterification of the compound of formula IV with a chiral, non-racemic diol such as (IS,2S,3R,5S)-(+)-pinanediol, 1,2-diphenylethan-1,2-diol or butan-2,3,-diol, because so doing introduces additional chiral centers into the molecule. This permits resolution of the chiral p- WO 93/10127 PCT/US92/09845 12 center a to the boron atom, using known per se methods for separation of diastereomers, such as HPLC, or fractional crystallization. This is illustrated in the reaction scheme of Figure 1, where the isomers of the compound of formula VI in which the boronic acid is protected with (1S,2S,3R,5S)-(+)-pinanediol can be separated by HPLC to give compounds VIa and VIb.

Alternatively, the isomers of the hydrochloride of the compound of formula VII, with the same boron protecting group, may be separated by fractional crystallization in a solvent such as ethyl acetate, or a dichloromethane/ethyl acetate mixture, isopropanol, or ethanol to give compound VIIb as a single isomer with the R configuration at the carbon attached to boron.

A further advantage of using pinanediol is that the boronate esters so formed are more stable than those derived from other diols, for example, pinacol, with which significant loss of the protecting group is often observed during chromatography. This is useful in both purification and isomer separation by chromatography on silica gel, since better recovery of the desired material is achieved.

In a slight modification of the synthesis described above, a derivatized pyrrole of formula III can be directly esterified with a diol of the formula V. The resulting ester of the formula IIIA WO 93/10127 PCT/US92/09845 13 B o 0

(IIIA)

R o can be reduced in the same manner as the compound of formula III, yielding the protected prolineboronic acid ester of formula VI. In cther words, the order of the steps in which the pyrrole ring is reduced and the boronic acid group is esterified may be reversed.

The prolineboronic acid esters thus produced are easily coupled to activated carboxylic acids such as those typically used in peptide synthesis, for example a nitrogen-protected amino acid to yield a compound of the formula X

BO

N

R2/ h X

(X)

0 R 2 Swherein -COOR is an amino protecting group of the sort commonly used in peptide synthesis, so that R is, fo' example, tert-butyl, benzyl, or fluorenylmethyl, and R 3 is the side chain of a naturally occurring amino acid, optionally with appropriate protecting groups of the sort commonly used in peptide synthesis.

c 1 WO 93/10127 PCT/US92/09845 14 Compounds of formula X contain protecting groups both on the boronate and on the amino acid nitrogen. It may be necessary to remove either or both protecting groups for biological activity or for further chemical manipulation. The protecting groups may be removed in either order. Various methods for removing these protecting groups are described below.

Removal of the nitrogen protecting group may be achieved by known methods to yield a compound of the formula XI.

NX

(XI)

R

3 The ester group which protects the boronic acid moiety is stable to neutral and acidic organic media but many boronate esters are cleaved rapidly under mildly basic (pH 7.5) aqueous conditions to yield the boronic acid. In the case of boronate esters of pinanediol, however, hydrolysis is known to be difficult, and special conditions are required for removal of the pinanediol. See for example Matteson et al. Am.

Chem. Soc., 102, 7590 (1980)] and Brown et al. [J.

Organometallic Chem., 385, 15 (1988)]. These methods are not suitable for the removal of pinanediol from a compound of formula VI, X, or XI. We have found several methods for removal of pinanediol from a boronate such as compound VI, X or XI. Thus, removal thereby inhibiting enzymatic action upon the substrate.

WO 93/10127 PCT/US92/09845 of the pinanediol may be achieved under mild conditions using an oxidizing agent capable of cleaving 1,2 diols to remove the pinanediol from the equilibrium and hence drive it in the direction of the free boronic acid. For example, treatment of compounds of formula VI and X, in which the protecting group is pinanediol, with sodium metaperiodate in aqueous aimmarlium acetate and acetone at ambient temperature yields compounds of formula IV and XII, respectively.

OH

CN

H

R 0 0(XII) "I o 0 R This reaction is conveniently carried out in water, optionally with an added buffer such as ammonium acetate or disodium hydrogen phosphate, at a pH between 3 and 10, preferably 6 to 8, and a temperature of 0 to 80 OC, preferably 20 to 40 oC, in the presence of a water miscible organic cosolvent such as acetone, methanol, ethanol, THF, or acetonitrile. Suitably the oxidizing agent is a non-nucleophilic oxidant capable AN of cleaving 1,2-diols such as periodic acid or its salts or permanganate salts. Under these conditions oxidative cleavage of the carbon-boron bond is not observed. It will be appreciated that this method is applicable to any boronic acid protected with pinanediol. Furthermore, it is applicable to any boronate protecting group which is a 1,2-diol, WO 93/10127 PCT/US92/09845 16 although it is particularly useful for protecting groups where simple aqueous hydrolysis is slow or incomplete.

In the case of a pinanediol boronate ester of a compound containing an unprotected amine, such as a compound of formula XI, the method described above may also be employed, but a second new method is preferable for compounds of this type. This method consists of applying an aqueous solution of a compound of formula XI, at pH 4 or lower, to a column of a cation exchange resin, and eluting the column with water or dilute acetic acid to remove the pinanediol.

This removes the pinanediol from the equilibrium, and thus drives the reaction in the direction of hydrolysis. The column is then eluted with dilute aqueous ammonium hydroxide to remove the product, which after evaporation and acidification is obtained as a salt of the compound of formula XIII.

OH

N (XIII)

H

2

AOH

SR

3 Suitably, a strongly acidic cation exchange resin, for example a sulfonic acid type of resin is used, such as, for example, Dowex 50. The pinanediol eluted from the resin may be recovered from the water solution and reused. This is most conveniently achieved by passing the water solution through a i _1_1 I W 93/10127 PCT/US92/09845 17 column of a nonionic polymeric adsorbent, such as Amberlite® XAD-200, which adsorbs pinanediol almost quantitatively. The pinanediol is removed from the column by elution with methanol or ethanol. The two operations of ion exchange and pinanediol adsorption may be combined in a single process in which water is recycled from one column to the other using a pump. This has the advantage of requiringmuch smaller amounts of water, and allows the process to be continued long enough to achieve a high conversion to the product.

Persons skilled in the art will appreciate that the above-described method for removing pinanediol using a cation exchange resin is only appropriate for compounds containing a basic functional group, such as an unprotected amine.

A third method is also applicable to pinanediol esters of compounds containing an unprotected amine, such as a compound of the formula XI. This method consists of transesterification of the pinanediol boronate with 4 another boronic acid of the formula R -B(OH) 2 in a two-phase system. R represents a C 1 12 hydrocarbon group, which may be composed of straight, branched or cyclic alkyl chains and phenyl rings.

4 R is preferably phenyl. One of the phases is water adjusted to a pH below 7, preferably pH 1-4, and the other is a hydrocarbon organic solvent such as hexane, petroleum ether, or toluene. Thus, treatment of a compound of formula XI with phenylboronic acid in a mixture of water at pH 1 and hexane, followed by separation of the phases, produces the pinanediol ester of phenylboronic acid in the organic phase, 9- I P1L~1 L II i It WO 93/10127 PCT/US92/09845 18 which may be recovered simply by evaporation, and a solution of the free boronic acid of formula XIII in the aqueous phase, which may be isolated using an ion exchange resin in a similar manner to that described above. In this system the only component which is soluble in the organic phase is the pinanediol phenylboronate, thus removing the pinanediol from the equilibrium. The compound of formula XI, and the compound of formula XIII which is formed, both remain in the aqueous layer, since neither are soluble in hydrocarbon solvents. The reaction may be carried out with any boronic acid with a hydrocarbon sidechain, providing its pinanediol ester is soluble in hydrocarbon solvents.

The fully deprotected compound of formula XIII may also be prepared by removal of the nitrogen protecting group from a compound of the formula XII using known methods. It will be appreciated that compounds of formula X, XI, XII, and XIII generally posess two chiral centers. One is adjacent to the boron atom, and the other is present in the amino acid moiety, except when that moiety is glycine. It will be further appreciated that the pure single diastereoisomers of these compounds are more desirable for biological use than mixtures of diastereoisomers.

Accordingly it is important to be able to produce these compounds as pure single isomers. In principal, since amino acids are generally available as single enatiomers, this may be achieved by separating the mixture of diastereoisomers formed by coupling an ioptically pure amino acid with racemic prolineboronic acid, using known techniques. Nevertheless, it has WO 93/10127 PCT/US92/09845 19 been found that, except in the special case of valine, such separations are often difficult and time consuming. Thus it is preferable to use a form of prolineboronic acid which is a single isomer at the chiral center adjacent to boron, since no isomer separation is then necessary after coupling to an optically pure amino acid. The present invention provides an easy means for resolving the enantiomers of prolinetoronic acid.

The following examples further illustrate the invention.

Example 1 1-(1,l-Dimethylethoxycarbonvl)-pyrrole-2-boronic acid To a solution of tetramethylpiperidine (8.8 mL, 52 mmol) in THF (275 mL) at -78 °C under an argon atmosphere was added a 2M solution of butyllithium in hexanes (26 mL, 52 mmol). After 15 min, 1-(1,1-dimethylethoxycarbonyl)-pyrrole (8.35 g, in THF (10 mL) was added and the solution was 0 stirred for 4 h at -78 C. Triethylborate (30 mL, 176 mmol) was then added and the mixture was allowed to warm to room temperature over 3 h. After an additional 12 h the reaction mixture was diluted with ether (500 mL) and washed with 1M aqueous KHSO 4 (3 x 100 mL) followed by 1M aqueous NaHCO 3 (1 x 100 mL).

Drying over MgSO 4 and rotary evaporation gr-duced a brown solid which was purified by flash chromatoqraphy over silica gel (1:9 EtOAc:Hexane) to yield 8.7 g of a white crystalline solid (mp 101.0 101.5 i- 12 F+LnlLII~- WO 93/10127 PCT/US92/09845 H NMR (CDC1 3 6 1.65 9 6.26 J 3.3 Hz, 1 7.10 (dd, J 1.6, 3.2 Hz, 1H), 7.15 2 7.44 (dd, J 1.6, 3.2 Hz, 1H); 13C NMR (CDC1 3 27.9, 85.5, 112.0, 127.0, 128.7, 152.0; CIMS m/z rel int) 212 11), 156 (100), 138 Anal. Calcd for CH 14 BN0 4 C, 51.23, H, 6.69, N, 6.64. Found: C, 51.22, H, 6.51, N, 6.67.

Example 2 1-(1,1-Dimethylethoxycarbon1)-pyrrolidine-2boronic acid A solution of 6.15 g (24 mmol) of 1-'(1,1-dimethylethoxycarbonyl)-pyrrole-2-boronic acid, produced as in Example 1, in EtOAc (100 mL) was hydrogenated over 5% Pt C (ca. 500 mg) at 50 psi for 24 to 48h. The resulting suspension was filtered through a pad of Celite and concentrated. This material was chromatographed on silica gel using sequential elutions of 9:1 hexanes:EtOAc then acetone. The acetone fractions were concentrated to produce 6.05 g of the desired compound as a clear glass that crystallized upon removal of trace solvents (mp 100-1010C).

H NMR (CDC1 3 6 1.42 9 1.6 2.15 (m, 3.1 3.6 2 3C NMR (CDC1 3 6 25.1, 25.7, 28.4, 45.6, 46.2, 78.6, 154.5; CIMS m/z rel int) 116 (100), 70 Anal. Calcd for

C

9

H

18

BNO

4 C, 50.27, H, 8.44, N, 6.51.

Found: C, 50.52, H, 8.22, N, 6.58.

1' WO 93/1 01 27 PCT/US92/09845 21 Examp~le 3 (lS.2S.3R,5S'-Pinanediol l-(l,1-dimethylethoxycarbonyl) -pyrrolidine-2S-boronate and f 2S. 3R.5S) -Pinanediol 1- l-diinethylethoxycarbonyl) -pyrrolidir'e-2R-boronate A Elution of 1-(1,1-dimethylethoxycarbonyl)pyrrolidine-2-boronic acid, produced as in Example 2, (1.52 q,7.1 mmol) and (1S,2S,3R,5S)-(+)-pinaned.iol (1.36 g, 8.0 mmol) was stirred at room temperature in ether (25.mL) for 2 h. Concentration and flash chromatography over silica gel (85:15 hexanes:EtOAc) produced 2.1 g of a 1:1 mixture of the two diastereomers. These were separated by HPLC over a 300 X 3.9 mm column of microporasil A eluting with methyl tert-butyl ether:hexanes and using u.v.

detection at 220 nm. The isomer (1S,2S,3R,5S)-pinanediol l-(l,1-dimethylethoxycarbonyl) -pyrrolidine-2S-boronate eluted first under these conditions.

S-isomer: H NMR (C D: 6 0.55 3 1.09 3 1.52 9 1.60 3 1.2 2.2 (in, 8 3.1 3.5 (in, 3 4.11 (in, 0.3 4.33 (in, 0.7 13C NMR (C D 6 6 2 3. 9, 2 6. 6, 2 7. 1, 27.3, 28.4, 28.6, 28.8, 36.0, 38.2, 39.9, 46.1, 51.9, 78.3, 78.5, 85.7, 154.9.

WO 93/10127 PCr/US92/ 09845 22 R-isomer: HNMR (C 6 D 6) 6 0.52 3 1.08 3 1.52 9 1.61 3 1.2 2.2 (mn, 8 3. 1 3. 6 (mn, 3 4. 021 (mn, 0. 3 H) 4. 25 (mn, 0.7 H) 13C NMR (C6D6) 23.9, 26.6, 27.1,.27.3, 28.4, 28.7, 28.9, 35.8, 38.2, 39.6, 46.2, 57 78.1, 78.5, 85.7, 154.5.

It will be recognized that (1R,2R,3S,5R)-pinanediol- 1-dimethylethoxycarbonyl) -pyrrolidine-2S-boronate and (1R, 2R, 3S, 5R) -pinanediol- 1- 1-diinethylethoxycarbonyl) -pyrrolidine-2R,-boronate could be produced in an analogous manner, starting with (lR,2R,3S,5R)-(-)-pinanediol.

Example 4 (1S,2S. 3R. 5S)-Pinanediol pyrrolidine-2S-boronate hydrochloride A solution of (lS,2S,3R,5S)-pinanediol- 1- 1-dimethylethoxycarbonyl)-pyrrolidine-2S-boronate, produced as in Example 3 (28.5 mng, 0.08 inmol) was stirred in a solution of dry HCl in EtOAc (approximately 3M). After 2 h the solution was concentrated twice from EtOAc to produce 21.2 mgj (91%) of the desired hydrochloride as a white solid (mp 204 0 C (dec)).

1NMR (CDC1 6 0.83 3 1.14 J 3 11Hz, 1 H) 1. 29 3 H) 1. 45 3 11) 1.8 5 2. I(mn, 6 H) 2. 17 2. 50 (in, 3 H) 3. 18 25 (in, 1 H), 3. 45 (bs, 2 4. 42 (dd, J 1. 8, 8. 6Hz, 1 H) 8. F_ 7L WO093/10127 PCT/US92/09845 23 (bs, 1H), 10.56 (bs, 1H); 13CNMR (CDC 1 3 6 23.9, 24.5, 26.5, 27.0, 27.2, 28.4, 34.9, 38.2, 39.4, 45.8, 51.2, 79.0, 87.6; CIMO7 m/z rel int) 250 100); HRMS (El) for C 14H 24BNO 2calcd 249.1900, found 249.1899.

It will be recognized that (1R,2R,3S,5R)-pinanediolpyrrolidine-2S-borola-te hydrochloride could be made in an analogous maniner.

Example (1S,2S,3R,5S',-Pinanediol pvrrolidine-2R-boronate hydrochloride A solution of (lS,2S,3R,5S)-pinanediol- 1- 1-dimethylethoxycarbonyl) -pyrrolidine-2R-borona-te, produced as in Example 3 (18. 3 mng, 0. 05 minol) was treated with dry HCI in EtOAc as above. Work-up produced 14.3 mng of the desired hydrochloride as a white solid (mp 248 '2 (dec)) IH NMR (CDCl 3 6 0.83 3 1.14 J 11Hz, 1 1.29 3 H) 1.45 3 1.85 -2.15 (mn, 6 2.17 2.50 (mn, 3 3.18-3.25 (mn, 1 H), 3.45 (bs, 2 4.42 (dd, J 1. 8, 8. 6Hz, 1 H) 8.8 0 (bs, 1 10.56 (bs, 1 H)n 3C NMR (001 3 6 23.9, 24.5, 26.5, 27.0, 27.2, 28.5, 34.9, 38.1, 39.4, 45.8, 51.2, 79.0, 87.,8; CIMS in/z rel int) 250 100) HRMS (El) for C1 H BN0 2 calcd 249.1900, found 249.1903.

WO093/10127 PCTr/US92/09845 24 It will be recognized that (lR,2R,3S,5R)-pinanediol pyrrolidine-2R-boroniate hydrochloride could be made in an analogous manner.

Exagmple 6 (1S,2S,3R,5S)-Pinanediol 1- 1-dimethyvlethoxycarbonyl) -pvrrole-2-boronate A solution of l-(l,l-diinethylethoxycarbonyl)pyrrole-2-boronic acid, produced as in Example 1 (1.36 g, 6..45 inmol) and (1S,2S,3R,5S)-(+)--pinanediol (1.10 a, 6.45 minol) was stirred in 20 mL of ether for 4 h. Rotary evaporation followed by flash chromatography over silica gel (95:5 hexane:EtOAc) produced 1.83 g of the desired product as a clear oil.

'H NMR (CDCl 3 6 0.90 3 H) 1. 30 3 H), 1L41 J 11 Hz, 1 1.50 3 1.50 3 1.59 9 1.96 (in, 2 2.21 J 6Hz, 1 2.1I6 2.40 (mn, 2 4.45 (dd, J 2, 8Hz, 1 H), 6.20 J 3Hz, 1 6.65 J 3Hz, 1 7.40 13 J 3Hz, 1 C NMR (CD 3 6 24 .0, 26.4, 27.2, 28.1, 28.6, 35.5, 38.3, 39.8, 51.8, 79.8, 83.6, 83.9, 111.6, 123.2, 124.7, 150.0; CIMS m/z rel int) 346 246 (81) 153 (100) 135 (56).

It will be recognized that (1R,2R,3S,5R)-pinanadiol- 1- 1-dimethylethoxycarbonyl) -pyrrole-2-boronate could be made in an analogous manner.

S.-

WO 93/10127 PCT/US92/09845 Example 7 1-(1,l-Dimethvlethoxvcarbonyl)-pyrrolidine-2-boronic acid from l-(ll-dimethvlethoxvcarbonl)-pyrrolidine To a solution of l-(1,l-dimethylethoxycarbonyl)pyrrolidine (17.1 g, 100 mmol) in diethyl ether (200 mL) at -78 oC under an atmosphere of nitrogen was added 1.3M sec-butyllithium in cyclohexane (92.3 mL, 120 mmol) whilst maintaining the temperature below OC. After addition was complete, the reaction mixture was stirred at -78 OC for 4 h.

Trimethylborate (31.1 g, 300 mmol) was added and the mixture was allowed to warm to room temperature over 3h'. After an additional 12h, water (150 mL) was added followed by 2M NaOH (200 mL). The aqueous phase was isolated and the organic phase was reextracted with 2M NaOH (150 mL). The combined basic extracts were acidified to pH 3 using 2M HC1 and extracted using EtOAc (5 x 200 mL). The combined organic extracts were dried (Na 2

SO

4 and concentrated to afford the desired product as a white crystalline solid (15.49g, identical with the material produced in Example 2.

i Example 8 (1S,2S,3R,5S)-Pinanediol l-(1,l-dimethylethoxycarbonvl)-pvrrolidine-2RS-boronate To a stirred solution of the material obtained in Example 7 (15.49 g, 72.0 mmol) in chloroform (250 mL) was added (IS,2S,3R,5S)-(+)-pinanediol (12.77 g, i I _I WO 93/10127 PCT/US92/09845 26 mmol). After stirring at room temperature under a nitrogen atmosphere for 16 h, the solvent was removed and the residue purified via flash chromatography over silica gel (hexane/EtOAc 9:1, 4:1) to give the desired product as a 1:1 mixture of diastereomers as an oil (23.62 g, 67.7% based on 1-(l,l-dimethylethoxycarbonyl)-pyrrolidine). This was identical with the mixture of isomers produced in Example 3.

1H NMR (CDC13): S 0.85 3H), 1.12-1.21 (m, 1H), 1.29 3H), 1.41 3H), 1.45 9H), 1.81-2.20 8H), 2.28-2.39 1H), 3.04-3.18 (m, 13 1H), 3.34-3.45 2H), 4.28-4.38 1H); C NMR (CDC13 6 23.7, 26.2, 27.1, 28.5, 35.5, 38.2, 39.6, 46.1, 78.0, 78.8, 85.7, 85.8, 154.7; CIMS m/z rel int) 350 100), 294 250 Example 9 Analytical Method for the Diastereoisomers of (1S,2S,3R,5S)-Pinaneulol pyrrolidine-2-boronate hydrochloride.

A reagent solution of 0.2 M phenyl isothiocyanate in dichloromethane-triethylamine was prepared. The sample to be analyzed (1-5 mg) was treated with pL of the reagent solution per imole of analyte and the clear solution was allowed to stand at room temperature for 15 min. A 1 pL sample of the solution was then diluted in 1.00 mL of HPLC-grade acetonitrile and 10 pL of this solution was analyzed by HPLC (column: YMC AQ-303 S-5 120A, 4.6 x 250 mm; am- WO 93/101227 PCT/US92/09845 27 mobile phase: 65% MeCN 35% 25 mM ammonium phosphate, pH 7.5; flow rate 1 mL/min; detection by UV at 254 nm). The phenylthiourea derivative of the R isomer of proline boronic acid elutes at about 6.4 min, its epimer elutes at about 7.8 min, and unreacted phenyl isothiocyanate, which serves as an internal standard, elutes at 12.2 min.

Example (1S,2S,3R,5S)-Pinanediol pyrrolidine-2RS-boronate hydrochloride A stirred solution of (1S,2S,3R,5S)-pinaneaiol l-(1,1-dimethylethoxycarbonyl)-pyrrolidine-2RS-boronate (224 g, 0.64 mol) in diethyl ether (900 mL) was cooled in ice and dry HC1 gas passed into the solution for min at 10-18 The solution was stirred at room temperature overnight, cooled again in ice and the precipitate filtered off. The solid was washed with cold ether (400 mL) followed by petroleum ether/diethyl ether 9:1 (200 mL) and dried under vacuum to give the desired hydrochloride as a white solid (113 g, 62%) (mp 228-234 0 Analysis of this material by HPLC as described in Example 9 showed it to be a 60:40 mixture of R:S isomers of the boronic acid.

4 s 1 1 WO 93/10127 PCT/US92/09845 28 1H NMR (CDC13): 6 0.83 3 1.14 J 11Hz, 1 1.29 3 1.45 3 1.85 2.15 6 2.17 2.50 3 3.18-3.25 1 H), 3.45 (bs, 2 4.42 (dd, J 1.8, 8.6Hz, 1 8.80 13 (bs, 1 10.56 (bs, 1 C NMR (CDC1 3 6 23.9, 24.5, 26.5, 27.0, 27.2, 28.4, 34.9, 38.2, 39.4, 45.8, 51.2, 79.0, 87.6; CIMS m/z rel int) 250 100); Anal. Calcd for C4H24BNO 2 HC1: C, 58.87, H, 8.82, N, 4.90, Cl, 12.41. Found: C, 58.40, H, 8.86, N, 4.81, Cl, 12.39.

A similar reaction on a 29 g, 101 mmol scale using ethereal HC1 (approx. 4.5M, 200 mL) and EtOAc (150 mL) as solvent yielded the hydrochloride (11.1 g, 47%) as a 81:19 mixture of R:S isomers Example 11 (1S,2S,3R,5S)-Pinanediol pvrrolidine-2R-boronate hydrochloride by fractional crystallization.

Method A: The 60:40 isomeric mixture obtained in Example (1.18 g 4.13 mmol) was dissolved in CH 2 C1 2 (65 mL) with slight warming, and the solution filtered. The filtrate was diluted with EtOAc (65 mL) and crystallization began within a minute. The suspension was stirred for 1-2 h at room temperature and the first crop of solid was collected and the diastereomeric ratio determined as described in Example 9 (540 mg, 46%, R:S ratio 97.1:2.9). Solvent i L i---i I- WO 93/10127 PCT/US92/09845 29 was distilled from the filtrate until most of the CH2C12 was removed, then the residual EtOAc solution was stirred at room temperature overnight to afford a second crop of off-white solid (346 mg, 29%, R:S ratio 39.2:60.8). The first crop was recrystallized from isopropyl alcohol (10 mL) to afford 430 mg recovery) of material >99% 2-R isomer. (mp 269-272 °C (dec)) [a] 2 5 D +0.700 (c=1.15, MeOH) H NMR (CDC13): 6 0.83 3 1.14 J 11Hz, 1 1.29 3 1.45 3 1.85 2.15 6 2.17 2.50 3 3.18-3.25 1 H), 3.45 (bs, 2 4.42 (dd, J 1.8, 8.6Hz, 1 8.80 13 (bs, 1 10.56 (bs, 1 C NMR (CDC1 3 6 23.9, 24.5, 26.5, 27.0, 27.2, 28.5, 34.9, 38.1, 39.4, 45.8, 51.2, 79.0, 87.8; CIMS m/z rel int) 250 100); Anal. Calcd for C 14

H

24

BNO

2 HC1: C, 58.87, H, 8.82, N, 4.90, Cl, 12.41. Found: C, 58.64, H, 8.79, N, 4.90, Cl, 12.66.

Method B: A suspension of (1S,2S,3R,5S)-pinanediolpyrrolidine-2RS-boronate hydrochloride as a 1:1 mixture of isomers (850 mg, 2.98 mmol) in EtOAc mL) was heated under reflux with stirring for 4 h. The mixture was filtered hot and the collected solid dried to give material enriched in the R isomer (541 mg R:S ratio 2:1. Evaporation of the filtrate yielded material enriched in the S isomer (217 mg), R:S 1:4. The filtered solid (500 mg) was treated in the same way with EtOAc (45 mL) for 1.5 h and again filtered hot to yield a solid (366 mg, 73%), R:S 7:1. This material was again treated with EtOAc p.

i; I 1.1L- I ar~-r~ WO 93/10127 PCT/US92/09845 (38 mL) for 1.5 h. The solid isolated (287 mg, 78%) now had R:S ratio 97:3. The spectral properties were the same as those of material obtained by method A.

Example 12 1-(1,1-Dimethylethoxycarbonvl)-pyrrolidine-2-boronic acid from (1S,2S,3R,5S) pinanediol 1-(1l,1-dimethylethoxycarbonyl)-pyrrolidine-2-boronate To a solution of (1S,2S,3R,5S)-pinanediol- -dimethylethoxycarbonyl)-pyrrolidine-2RS-boronate from Example 8 (1.9 g, 5.44 mmol) in acetone (80 mL) was added 0.1M ammonium acetate solution (80 mL) and sodium metaperiodate (3.49 g,16.33 mmol). The reaction mixture was stirred at room temperature for h, then the acetone was evaporated and the residue was treated with 2M NaOH solution. This aqueous phase was washed with CH 2 C1 2 (2 x 80 mL), acidified with 2M HC1 to pH 3 and extracted with CH 2 C1 2 (4 x mL). The combined organic extracts were dried (Na 2

SO

4 and concentrated to afford the desired product as a white foamy solid (890 mg, 76%), identical by NMR with the material prepared in Example 2. The boronic acid was derivatized with pinacol for purposes of analysis.

I IC--~~q WO 93/10127 PCT/US92/09845 31 Example 13 Pinacol 1-(1,-dimethylethoxycarbonyl)pyrrolidine-2RS-boronate To a stirred solution of the boronic acid from Example 12 (890 mg, 4.14 iinmol) in chloroform was added pinacol (489 mg, 4.14 mmol). After stirring for 16h at room temperature, the solvent was removed and the residue was purified via chromatography over silica gel (hexane/EtOAc, 4:1) to give the desired product as a white solid (1.04 g, 85%) (mp 73-75 oC).

H NMR (CDCl3): 6 1.18 6H), 1.21 6H), 1.38 9H), 1.57-2.00 4H), 2.98 (br s, 1H), 3.27 (mi, 2H) 13C NMR (CDC13): 6 24.3, 24.5, 24.7, 24.9, 25.3, 27.0, 27.6, 28.4, 28.6, 43.6, 45.8, 46.3, 78.8, 83.2, 154.4, 154.8; CIMS m/z rel int) 298 242 (100, MH+ tBu), 198 (30, MH+ Boc); Anal.

Calcd for C 15

H

2 8 BN0 4 C, 60.62, H,9.50, N, 4.71.

Found: C, 60.94, H, 9.65, N, 4.88.

Example 14 N-(l,l-Dimethylethoxvcarbonyl)-L-valylpyrrolidine-2Rboronate (1S,2S,3R,5S)-pinanediol ester A solution of t-BOC-L-Valine (351.7 g, 1.62 mol) in CH2C12 (1.6 L) was cooled with an ice bath and a solution of dicyclohexylcarbodiimide (161.8 g, 0.784 mol) in CH2C 2 (0.75 L) was added within min at 0-2 After addition the solution was i- i: I WO 93/10127 PCT/US92/09845 32 stirred for 3.5 h at 0-5 The white precipitate was filtered off and washed with CH 2 Cl 2 (0.2 The resulting clear solution was added at 18-20 °C (waterbath cooling) to a solution of (1S,2S,3R,5S)-pinanediol pyrrolidine-2RS-boronate hydrochloride (210 g, 0.735 mol), prepared as in Example 10, in CH 2 C1 2 (2.0 L) containing N-methylmorpholine (164 g, 1.62 mol). The mixture was allowed to stir at room temperature overnight. The cloudy solution was filtered through a 16 cm dia. x 2 cm high bed of silica gel (200-425 mesh) and washed with CH 2 C12 (1.5 The solvent was evaporated to yield a highly viscous oil (542 This oil was dissolved in ethyl acetate (0.7 L) and the mixture cooled in an ice bath. Crytals formed, which were filtered off at low temperature, and washed with cold ethyl acetate (0.1 The wet filter cake was transferred into petroleum ether (0.65 L) and stirred at room temperature for 1 h. The white solid was filtered, washed with cold petroleum ether (0.1 L), and dried to constant weight to yield the title compound as a white solid (113.4 g) (mp 128-130 oC).

All the mother liquors were combined and concentrated to a volume of approx. 0.8 L. After standing for 2 days in the freezer a solid formed, which was filtered off, and treated with petroleum ether as above to yield a beige solid (50.4 This was a mixture of impurities and the unwanted diastereoisomer. The mother liquor from above was concentrated and the residue purified over a silica gel column (14 cm dia.

x 60cm) using hexane/ethyl acetate (85:15) (14 L).

Appropriate fractions were collected, treated with petroleum ether, the solid collected by filtration and 11 1 WO 93/10127 PCT/US92/09845 33 dr-'d, to yield more desired product (18.5 The other diastereoisomer was also obtained (7.5 g) (mp 82-83 0 A second column was performed on the combined mixed fractions and mother liquors to yield additional pure compound (13.5 total combined yield 145.4 g of desired diastereoisomer (mp 128-130 OC).

H NMR (CDC13): 6 0.83 3 0.91 J 6.7Hz, 3 0.97 J 6.7Hz, 3 1.27 3 H), 1.35-1.45 I 1.39 3 1.41 9 H), 1.72-2.14 9 2.26-2.36 1 3.15 (dd, J 6.7, 10.1Hz, 1 3.43-3.51 1 3.70-3.81 (m, 1 4.19-4.28 2 5.29 J 9.2Hz, 1 H); 13 C NMR (CDC1 3 6 17.3, 19.2, 24.0, 26.3, 27.1, 27.2, 27.4, 28.4, 28.6, 31.4, 33.9, 35.5, 38.2, 39.6, 46.7, 51.2, 56.6, 77.8, 79.2, 85.8, 155.9, 170.2; CIMS m/z rel int) 449 100), 393 Anal. Calcd for C 24

H

41

BN

2 0 C, 64.28, H, 9.22, N, 6.25.

Found: C, 64.58, H, 9.33, N, 6.52.

Example L-valylpyrrolidine-2R-boronate (1S,2S,3R,5S)-pinanediol ester hydrogen maleate N-(1,1-Dimethylethoxycarbonyl)-L-valylpyrrolidine-2Rboronate (1S,2S,3R,5S)-pinanediol ester (248 mg, 0.553 mr-nol) was added to a stirred solution of dry hydrogen chloride in ethyl acetate. After 1.5 h the solvent was evaporated to leave the deprotected hydrochloride. The residue was partitioned between Ir Iri; r r^r---rrr WO 93/10127 PCT/US92/09845 34

CH

2 C1 2 and sodium carbonate solution, and the organic layer dried over magnesium sulfate. The organic layer contains the free base of the title compound, which exists as a cyclic form containing a nitrogen-boron bond, but reverts to the open form on adding acid. The organic solution was filtered into a solution of maleic acid (64 mg, 0.553 mmol) in methanol (5 mL), and the solvent evaporated to leave a crystalline residue (258 mg), which was recrystallized from ethyl acetate to give the title compound (193 mg, (mp 145-146 OC).

H NMR (CDC13): 6 0.84 3 1.08 J 6.9Hz, 3 1.13 J 6.9Hz, 3 1.26-1.31 (m, 2 1.29 3 1.38 3 1.72-2.15 (m, 7 2.24-2.38 2 3.28 (dd, J 6.9, 9.4 Hz, 1 3.38-3.47 1 3.73-3.78 1 4.14 (d, J 5.1Hz, 1 4.26 J 7.1Hz, 1 6.25 (s, 2 7.5-9.0 br, 4 1C NMR (CDC1 3 6 17.0, 18.4, 24.0, 26.3, 27.0, 27.1, 23.7, 30.0, 35.4, 38.2, 39.5, 47.3, 51.2, 56.6, 78.1, 86.2, 135.6, 166.3, 169.5; CIMS m/z rel int) 349 100), 197 Anal. Calcd for C 23

H

37

BN

2 0 7 C, 59.49, H, 8.03, N, 6.03. Found: C, 59.50, H, 8.13, N, 6.03.

SWO 93/10127 PCT/US92/09845 Example 16 L-valvlprrolidine-2R-boronic acid methanesulfonite a) cyclo-L-valylpyrrolidine-2R-boronic acid A solution of the maleate salt obtained in Example g, 10.8 mmol) in dilute acetic acid 60 mL) was loaded on to a column (3.5 cm deep x 4 cm dia.) of Dowex 50X2-200 ion exchange resin in the H+ form. The column was then eluted with acetic acid 14 L), water (42 L) and ammonium hydroxide solution (1:100 dilution of. commercial 0.880 solution). Pinanediol could be recovered from the neutral and acidic fractions. The product was found in early basic fractions, which were collected and washed with

CH

2 Cl2 (2 x 100 mL). The organic extracts were drjpd and concentrated to afford recovered free base of the starting material (741 mg, along with some pinanediol. The aqueous phase was lyophilized to afford the title compound, which exists in a cyclic form with a nitrogen-boron bond, as a white solid (1.52g, 66%) (mp 120-130 0

C).

H NMR (D 2 6 0.97 J 7.0 Hz, 3 1.06 J 7.0 Hz, 3 1.59-1.80 2 1.95-2.03 A. 2 2.41-2.51 1 2.62-2.69 1 H), 3.23-3.32 1 3.51-3.58 (m with overlapping 13 doublet, J 4.2 Hz, 2 C NMR (D 2 6 19.0, 21.7, 27.3, 30.7, 29.9, 49.6, 61.0, 170.3; IR -1 (cm 3400-3314, 3221-3108, 2961-2872, 1637, 1452-1369; CIMS m/z rel int) 375 p 1 WO 93/10127 PCT/US92/09845 36 M2H+-3H 2 197 (100, MH+-H 2 Anal. Calcd for C H 9BN203: C, 50.50, H, 8.95, N, 13.09.

Found: C, 50.43, H, 8.76, N, 12.93.

b) L-valylpyrrolidine-2R-boronic acid methanesulfonate To a stirred suspension of the cyclized boronic acid obtained above (5.17 g, 24.16 mmol) in acetonitrile (190 mL) under nitrogen was added a solution of methanesulfonic acid (2.32 g, 24.16 mmol) in acetonitrile (10 mL) dropwise over five minutes and the mixture stirred at room temperature for 2 h. The solid was collected by filtration, washed well with acetonitrile and diethyl ether and dried to afford the title compound as a white solid (6.14g, 82%) (mp 179-180 OC). Crystallization of this material from dimethylformamide/acetonitrile gave a 70% recovery of material in a single crop (mp 181-182 oC).

H NMR (D 2 0, phosphate, pH2): 6 0.99 J 6.8 Hz, 3H), 1.09 J 6.9Hz, 3H), 1.69-1.75 1H), 1.90-1.99 1H), 2.10-2.14 2H), 2.28-2.35 (m, 1H), 2.80 3H), 3.07 (dd, J 7.0 and 11.2 Hz, 1H), 3.46-3.51 1H), 3.75 J 9.0 Hz, 1H), 4.14 (d, J 5.1 Hz, 1H); the cis amide rotamer (ca, is also observed at 3.53-3.55 and 3.83 J 13 6.2 Hz) C NMR: 6 16.2, 18.4, 26.9, 27.1, 29.0.

38.8, 47.9, 49.0, 57.2, 167.2; peaks due to the cis amide rotamer are observed at 16.8, 24.3, 29.9, 57.8, 167.5; IR (cm 3387, 3000 2972, 2655, 1646, 1370, 1197; CIMS m/z rel int, ethylene glycol adduct) 241 (MH+ 100); Anal. Calcd for

C

10 H23BN206S: C, 38.72, H, 7.47, N, 9.03.

Found: C,38.65, H, 7.45, N, 8.44.

WO093110127 PCr/US92/09845 37 Example 17 N- -Dimethylethoxycarbonvl) -L-valylpyrrolidine-2R-, boronic acid To a stirred solution of N-(l,l-dimethylethoxycarbonyl)-L-valylpyrrolidine--2R-boronate (1S,2S,3R,5S)-pinanedio1 ester, pre~pared as in Example 14, (1.0 g, 2.3 mmol) in acetone (75 mL) was added ammonium acetate solution (60 ml, 0.1 M) and sodium metaperiodate (1.48 g, 6.91 mmol). The reaction mixture was stirred at room temperature for 48 h, then the acetone was evaporated. The residue was treated with 2M sodium hydroxide solution (100 mL), and washed wit CH2 C12 (2 x 50 mL). The aqueous layer was carefully acidified with 21M hydrochloric acid to pH 3 and extracted with CH 2Cl 4x70m) h combined organic extracts of the acid solution were dried over sodium sulphate and concentrated to afford the desired product as a white foamy solid (700mg, 97%) Further purification via chromatography over silica gel (CH 2 Cl 2 /methanol, 9:1) gave the boronic acid again as a white solid (449 mg, 62%) (mp 82-92 0

C).

HNMR (CDCl 3 6 0.95 J 5.7 Hz, 6H) 1. 42 9H), 1.55-1.80 (in, 11H) 1.80-2.20 (in, 4H), JWA 2.89-3.07 (mn, 1H), 3.30-3.55 (ini, 1H), 3.55-3.65 (m, 1H), 4.10-4.30 (mn, 1H), 5.34 J 9.2 Hz, 1H-); 13 C NMR (CDC1 3 6 18.-0' 19. 1, 26. 3, 27 28. 3, 31.2, 46.1, 52.0, 55.7, 79.5, 155.6, 170.8; IR -1 (cm )3395-3319, 2971-2875, 1711, 1619, 1400, 1174; CIMS m/z rel int, ethylene glycol adduct) 341(MH 100), 285(MH +-tBu, 67) 241(MH -BOC,I P~/US92/0984S 38 ExaMple 18 L-valvlipvrrolidine-2R-boronic acid hydrochloride N- 1-Dimethylethoxycarbonyl) -L-valylpyrrolidine-2Rboronic acid, obtained in Example 17'(250 mq, 0.796 mmol) was stirred with HC1/ether (4.5M, 20 mL) at room temperature un-der nitrogen for 1.5 h. The solvent was then evaporated and the residue triturated with diethyl ether (3 x 10 mL) and each time the ether was decanted. The residue was dried to yield the title compound as a white powdery solid (172 mg, 86%) (mp 211-213-C).

1 HNMR 0, phosphate pH 6 0.99 J= 6.9 Hz, 3 1.09 J 7.0 Hz, 3 1.67-1.76 (in, I. 1.87-2.01 (in, 1 2.09-2.15 (in. 2 H), 2.28-2.35 (in, 21 3.07 (dd, J 7.0 and 11.4 Hz, 1 3.48 (dt, J 6.7 and 10.3 Hz, 1 3.73 (dt, J -1.7 and 10.2 Hz, 1H), 4.14 J =5.2 Hz, 1H); 13 C NMR: 6 16.0, 18.3, 26.9, 27.1, 28.9, 47.9, 48.9, 57.2, 167.3; IR (cm- 1 3400-2800, 3368, 2970/2880, 1635, 1475-1378, 1400; CIMS m/z (%rel int, ethylene glycol adduct) 241 (MH+ 100).

WO 93/10127 PCT/US92/09845 39 Example 19 cyclo-L-Valvlpyrrolidine-2R-boronic acid by transesterification with phenylboronic acid A solution of L-valylpyrrolidine-2R-boronate (1S,2S,3R,5S)-pinanediol ester hydrochloride, prepared as in Example 15 (500 mg, 1.3 mmol) in 1M hydrochloric acid (10 mL) containing hexane (20 mL) and phenylboronic acid (500 mg, 2.6 mmol) was stirred vigorously for lh at room temperature. The hexane was removed by decantation, then more hexane (20 ml) was addcd and the mixture stirred for a further 30 min.

The layers were separated and the combined hexane layers dried over sodium sulphate and concentrated to give pinanediol phenylboronate (331 mg, 99%) as a white crystalline solid. The aqueous layer was then passed through a column of Dowex 50 ion exchange resin. The column was eluted with water (200 mL), followed by ammonium hydroxide solution (1:100 dilution of commercial 0.880 solution, 50 ml).

Isolation of the basic fractions followed by lyophilization gave the free boronic acid (230 mg, 83%) as a white powder, identical by NMR with the material obtained in Example 16a.

*i

Claims (5)

1. An intermediate of the formula III OH (Mn) OH RO 0 wherein R is C 1 -6alkyl, C 3 6 cycloalkyl, benzyl, phenyl, phenyl substituted with one or more C 1 alkyl groups, or trimethylsilylethyl.

2. 1- 1-Dimethylethoxycarbonyl) -pyrrole-2-boronic acid.

3. A compound selected from the group consisting of 000 (1S,2S,3R,5S) -pinanedic:;1 1- 1-dimethylethoxy "-Tonyl) -yrldn-S boronate; o 0 000(1S,2S,3R,5S)-pinanediol 1-(1,1- 00 dimethylethoxycarbonyl) -pyrrolidine-2R-boronate; *0 (1R, 2R, 3S, 5R) -pinanediol 1- (1,1- dimethylethoxycarbonyl) -pyrrolidine-2S-boronate; and 00o(1R2R,3SPR)-ninanediol -11 0 00 dimethylethoxycarbonyl) -pyrrolidine -2R-boronate. 00A N

4. A compound selected from the group consisting of 3R, 5S) -pinanediol pyrrolidine-2S-boronate hydrochloride; (1,S3,S-pinanediol yrldn-R boronate hydrochloride; (lR, 2R,3S, 5R) -pinanediol pyrrolidine-2S-boronate hydrochloride; (lR, 2R, 3S, 5R) ~~LIIV pinanediol pyrrolidine-2R--boronate hydrochloride. 0

41-w 41 A compound selected from the group consisting of S1S,2S,3R,5S)-pinanediol 1-(1,1-dimethylethoxycarbonyl) -pyrrole-2-boronate; and (1R,2R,3S,5R)-pinanediol 1-(1, 1-dimethylethoxycarbonyl)-pyrrole-2-boronate. 6. A method for removing pinanediol as the protective ester group from a compound of the formula X B O (X) NON X H o 0 0 Ri wherein R 2 is a protecting group, and R 3 is the side chain of a naturally occurring amino acid, optionally with appropriate protecting groups, or from a compound of the formula XI wherein R is as defined above, which method comprises C IC R3 t C ;c 1 wherein R 3 is as defined above, which method comprises E' Itreating such a boronate ester with an oxidizing agent, preferably sodium metaperiodate, which is capable of C" (cleaving 1,2-diols. 1 7. A method for removing pinanediol as the protective ester group from a compound of the formula XI -42 S\(X) N \0 H 2 N) O 0 0 R3 wherein R 3 is the side chain of a naturally occurring amino acid, optionally with appropriate protecting groups, which method comprises applying an aqueous solution of such a boronate ester to a column of a cation exchange resin, preferably a strongly acidic cation exchange resin, eluting the column with water or dilute aqueous acid to remove the pinanediol, and finally eluting the column with dilute aqueous base to remove the free boronic acid product. 8. An intermediate of the formula X a o IR 0 o (x) so O N O 0 St R t4 1 wherein the protecting group is derived from pinanediol, and wherein R 2 is a protecting group, and R 3 .is the side chain of a naturally occurring amino acid, optionally with appropriate protecting groups. 9. N-(1,1-Dimethylethoxycarbonyl)-L-valylpyrrolidine- 2R-boronate (1S,2S,3R,5S)-pinanediol ester. <4 r L i 43 An intermediate of the formula XI 0 wherein the protecting group is derived from pinanediol, and wherein R 3 is the side chain of a naturally occurring amino acid, optionally with appropriate protecting groups. 11. L-Valylpyrrolidine-2R-boronate (1S,2S,3R,5S)- pinanediol ester or a salt thereof. DATED this 16th day of May 1995. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. By their Patent Attorneys: CALLINAN LAWRIE Iit I t h 'I Ii (i